PSB
CCCC icon

Piscataqua Savings Bank’s C4 Therapeutics CCCC Stock Holding History

Piscataqua Savings Bank’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-600
Closed -$2.77K – 348
2024
Q2 		$2.77K Hold
600
– – ﹤0.01% 316
2024
Q1 		$4.9K Hold
600
– – ﹤0.01% 305
2023
Q4 		$3.39K Hold
600
– – ﹤0.01% 305
2023
Q3 		$1.11K Hold
600
– – ﹤0.01% 344
2023
Q2 		$1.65K Hold
600
– – ﹤0.01% 327
2023
Q1 		$1.88K Hold
600
– – ﹤0.01% 328
2022
Q4 		$3.54K Hold
600
– – ﹤0.01% 301
2022
Q3 		$5K Hold
600
– – ﹤0.01% 278
2022
Q2 		$5K Buy
600
+199
+50% +$1.75K ﹤0.01% 281
2022
Q1 		$10K Hold
401
– – 0.01% 264
2021
Q4 		$13K Hold
401
– – 0.01% 258
2021
Q3 		$18K Hold
401
– – 0.02% 226
2021
Q2 		$15K Hold
401
– – 0.01% 241
2021
Q1 		$15K Buy
+401
New +$16K 0.01% 239

Other funds holding CCCC

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Piscataqua Savings Bank's CCCC Position: Q3 2024 in Review

Piscataqua Savings Bank sold out of C4 Therapeutics (CCCC) in Q3 2024, closing a stake of 600 shares — an estimated $2.77K sold.

Piscataqua Savings Bank first reported a position in CCCC in Q1 2021 and held it in 14 quarters. The position peaked at $18K in Q3 2021. 118 funds tracked by Wall St. Rank hold CCCC as of Q3 2024.

  • Piscataqua Savings Bank reported no remaining C4 Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Piscataqua Savings Bank sold 600 C4 Therapeutics shares in Q3 2024, an estimated $2.77K.
  • Piscataqua Savings Bank first reported a position in C4 Therapeutics in Q1 2021 and held it in 14 quarters.
  • Piscataqua Savings Bank's C4 Therapeutics position peaked at $18K in Q3 2021.
  • 118 funds tracked by Wall St. Rank held C4 Therapeutics as of Q3 2024.

Based on Piscataqua Savings Bank's 13F filing for Q3 2024, filed 15 Oct 2024.